![William Nichols](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 435 692 $ au 31/05/2026
William Garrett Nichols currently works at Candel Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Nichols also formerly worked at Chimerix, Inc., as Chief Medical Officer from 2014 to 2020, ViiV Healthcare Ltd., as Head-Global Development, Istari Oncology, Inc., as Chief Medical Officer from 2020 to 2022, GSK Plc, as Vice President-Clinical Development from 2008 to 2014, and Fred Hutchinson Cancer Research Center, as Head-Infection Control.
Dr. Nichols received his doctorate degree from Duke University and graduate degree from the University of Washington.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2026 | 52 493 ( 0,07% ) | 435 692 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 12/09/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Directeur Technique/Scientifique/R&D | 01/04/2022 |
| CHIMERIX, INC. | Directeur Technique/Scientifique/R&D | 07/04/2020 |
| GSK PLC | Corporate Officer/Principal | 01/04/2014 |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Corporate Officer/Principal | - |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
